HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wetz, K. Articles by Habermehl, K.-O. Search for Related Content PubMed PubMed Citation Articles by Wetz, K. Articles by Habermehl, K.-O. Agricola Articles by Wetz, K. Articles by Habermehl, K.-O.

Topographical Studies on Poliovirus Capsid Proteins by Chemical Modification and Cross-linking with Bifunctional Reagents

Institut für Klinische und Experimentelle Virologie, Freie Universität, Berlin, Hindenburgdamm 27, 1000 Berlin 45, Germany

Poliovirus capsid proteins comprise 15.1 lysines in VP1, 5.6 lysines in VP2, 11.7 lysines in VP3 and 5.5 lysines in VP4. Treatment with the monofunctional reagent N-succinimidyl 2,3-³H-proprionate leads to the modification of 3.4 lysines in VP1, 0.6 lysines in VP2, 2.0 lysines in VP3 and 0.03 lysines in VP4. Chemical modification with the monofunctional reagent N-succinimidyl 3-(4-hydroxy,5-¹²⁵I-iodophenyl)propionate results in a predominant labelling of VP1 and VP3, whereas VP2 is less accessible and VP4 is not modified. Cross-linking of poliovirus with bifunctional imidoesters, dimethyl suberimidate (DMS, 1.1 nm) and dimethyl adipimidate (DMA, 0.8 nm) leads to a new protein complex of mol. wt. which corresponds to the sum of VP1 and VP3. By cleavage with ammonia and electrophoresis on polyacrylamide gels in SDS, the proteins are identified as VP1 and VP3. This result gives evidence for a direct neighbourhood of VP1 and VP3 in the virus capsid. Treatment of the virus with the mono- and bifunctional reagents has no influence on the stability of the particle. The infectivity is reduced only by the bifunctional reagent.

Received 15 December 1978; accepted 7 February 1979.

This article has been cited by other articles:

				W. Chehadeh, P.-E. Lobert, P. Sauter, A. Goffard, B. Lucas, J. Weill, M.-C. Vantyghem, G. Alm, P. Pigny, and D. Hober Viral Protein VP4 Is a Target of Human Antibodies Enhancing Coxsackievirus B4- and B3-Induced Synthesis of Alpha Interferon J. Virol., November 15, 2005; 79(22): 13882 - 13891. [Abstract] [Full Text] [PDF]